Tags: Drug.
Lorcaserin (APD-356 trade name upon approval Belviq expected trade name during development Lorqess) is a weight-loss drug developed by Arena Pharmaceuticals. It has serotonergic properties and acts as an anorectic. On 22 December 2009 a New Drug Application (NDA) was submitted to the Food and Drug Administration (FDA) in the United States. On 16 September 2010 an FDA advisory panel voted to recommend against approval of the drug based on concerns over both safety and efficacy.
